Home / WBP1L Knockout Cell Lines

WBP1L Knockout Cell Lines

Gene: WBP1L

Official Full Name: WW domain binding protein 1 likeprovided by HGNC

Gene Summary: Predicted to enable ubiquitin protein ligase binding activity. Predicted to be involved in CXCL12-activated CXCR4 signaling pathway. Predicted to act upstream of or within hemopoiesis and positive regulation of protein ubiquitination. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO12626 WBP1L Knockout cell line (HeLa) Human WBP1L 1:3~1:6 Negative Online Inquiry
KO12627 WBP1L Knockout cell line (HCT 116) Human WBP1L 1:2~1:4 Negative Online Inquiry
KO12628 WBP1L Knockout cell line (HEK293) Human WBP1L 1:3~1:6 Negative Online Inquiry
KO12629 WBP1L Knockout cell line (A549) Human WBP1L 1:3~1:4 Negative Online Inquiry

Background

WBP1L Gene Knockout Cell Lines are advanced cellular models specifically engineered to silence the WBP1L gene, known for its role in various cellular processes including proliferation, differentiation, and response to stress. By employing CRISPR/Cas9 gene-editing technology, these knockout cell lines provide a precise mechanism for studying the distinct contributions and functions of the WBP1L gene in biological pathways.

The primary function of WBP1L Gene Knockout Cell Lines is to facilitate comprehensive investigations into the gene's biological role and its implications in diseases such as cancer. Researchers can utilize these cell lines to dissect signaling cascades and uncover the interplay between WBP1L and other molecular players in cell fate determination and disease pathology. This mechanistic understanding is crucial for identifying potential therapeutic targets and biomarkers.

In clinical and research settings, the scientific importance of WBP1L Gene Knockout Cell Lines lies in their utility for functional genomics studies and drug discovery. Knockout models allow for high-throughput screening of compounds, helping to identify novel inhibitors or enhancers that modulate WBP1L-related pathways. Moreover, these cell lines provide a robust platform for testing the efficacy of gene therapies aimed at restoring normal function in WBP1L-deficient cells.

Compared to alternative models, WBP1L Gene Knockout Cell Lines boast high specificity and sensitivity, ensuring reliable and reproducible results. Their generation through the CRISPR/Cas9 technique allows for minimal off-target effects, making them superior choices for precision research. Furthermore, these cell lines are readily adaptable for various culture conditions, providing flexibility for diverse experimental setups.

Researchers and clinicians benefit significantly from utilizing WBP1L Gene Knockout Cell Lines, as they offer insights not only into fundamental cellular mechanisms but also into translational applications that can pave the way for innovative therapeutic strategies.

Our company's expertise in biotechnological advancements and commitment to delivering high-quality research tools make us a trusted partner in your scientific endeavors. We strive to empower researchers by providing cutting-edge biological products that enhance the capacity for groundbreaking discoveries in genomics and cellular biology.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.